Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2000
11/23/2000WO2000069841A2 Benzofuranylaminoalcohols
11/23/2000WO2000069839A1 Hydroxamic and carboxylic acid derivatives
11/23/2000WO2000069838A1 Ion channel modulating agents
11/23/2000WO2000069831A1 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
11/23/2000WO2000069827A1 Hydroxamic and carboxylic acid derivatives
11/23/2000WO2000069824A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/23/2000WO2000069823A1 Ion channel modulating agents
11/23/2000WO2000069822A1 Hydroxamic and carboxylic acid derivatives
11/23/2000WO2000069821A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/23/2000WO2000069820A1 Cyclic amine derivatives and their uses
11/23/2000WO2000069819A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors
11/23/2000WO2000069818A1 MORPHOLINO-N-ETHYL ESTER DERIVATIVE OF AN INDOLE sPLA2 INHIBITOR
11/23/2000WO2000069815A1 Ureido-substituted cyclic amine derivatives and their use as drug
11/23/2000WO2000069515A1 Remote and local controlled delivery of pharmaceutical compounds using electromagnetic energy
11/23/2000WO2000069457A1 Protein a based binding domains with desirable activities
11/23/2000WO2000069455A2 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus
11/23/2000WO2000069431A1 Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory response
11/23/2000WO2000069426A2 Combination of nicotinic acid or nicotinamide with riboflavin for the treatment of pruritus, itching and inflammation disorders
11/23/2000WO2000043371A3 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
11/23/2000WO2000037502A3 Vascular endothelial cell growth factor antagonists and uses thereof
11/23/2000WO2000034295A3 Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation
11/23/2000WO2000031100A3 Benzylmaltosides as inhibitors of smooth muscle cell proliferation
11/23/2000WO2000030681A9 Antagonists of the alpha e beta 7 integrin as therapeutic agents for inflammatory diseases
11/23/2000WO2000020450A3 Calcium channel alpha-2/delta gene
11/23/2000WO2000004863A3 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
11/23/2000DE19922462A1 New phenylureidobenzyl-substituted spiro-imidazolidinedione derivatives, are inhibitors of leukocyte adhesion or migration or VLA-4 receptors, useful e.g. for treating inflammatory or allergic disease
11/23/2000CA2374559A1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
11/23/2000CA2374235A1 Production of complex carbohydrates
11/23/2000CA2374053A1 Secreted polypeptides and corresponding polynucleotides
11/23/2000CA2374045A1 Compositions isolated from skin cells and methods for their use
11/23/2000CA2374013A1 Protein a based binding domains with desirable activities
11/23/2000CA2373824A1 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus
11/23/2000CA2373666A1 Benzofuranylsulfonates
11/23/2000CA2373607A1 Cyclic amine derivatives and their uses
11/23/2000CA2373532A1 Morpholino-n-ethyl ester derivative of an indole spla2 inhibitor
11/23/2000CA2373500A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors
11/23/2000CA2373231A1 Extracellular signaling molecules
11/23/2000CA2373191A1 Full-length molecules expressed in human tissues
11/23/2000CA2372934A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/23/2000CA2372926A1 143 human secreted proteins
11/23/2000CA2372919A1 Remote and local controlled delivery of pharmaceutical compounds using electromagnetic energy
11/23/2000CA2372549A1 Ox2 receptor homologs
11/23/2000CA2372541A1 Sphingosine kinase enzyme
11/23/2000CA2372494A1 Compounds having cytokine inhibitory activity
11/23/2000CA2372426A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/23/2000CA2372098A1 Lawsonia derived gene and related flge polypeptides, peptides and proteins and their uses
11/23/2000CA2372068A1 Sulphostin analogue and process for producing sulphostin and its analogue
11/23/2000CA2372051A1 Imidazo-containing heterocyclic compounds, their compositions and uses
11/23/2000CA2370066A1 Thiazolopyrimidines useful as tnf.alpha. inhibitors
11/23/2000CA2369376A1 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer and for prevention of cancer in at-risk subjects
11/22/2000EP1054017A1 Salts of thrombin inhibitors
11/22/2000EP1053351A1 Novel molecules of the tnf receptor superfamily and uses therefor
11/22/2000EP1053343A2 Targeting of genetic vaccine vectors
11/22/2000EP1053332A1 Protein
11/22/2000EP1053323A2 Human receptor proteins
11/22/2000EP1053321A1 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same
11/22/2000EP1053312A2 Optimization of immunomodulatory properties of genetic vaccines
11/22/2000EP1053308A1 Dendritic enriched secreted lymphocyte activation molecule
11/22/2000EP1053307A1 Podocalyxin like sialomucins having selectin ligand activity
11/22/2000EP1053306A1 Secreted proteins and polynucleotides encoding them
11/22/2000EP1053255A1 THREE-DIMENSIONAL STRUCTURES AND MODELS OF Fc RECEPTORS AND USES THEREOF
11/22/2000EP1053254A2 COMPOSITIONS AND METHODS TO INHIBIT FORMATION OF THE C5b-9 COMPLEX OF COMPLEMENT
11/22/2000EP1053240A1 Glucocorticoid-selective antiinflammatory agents
11/22/2000EP1053239A1 Glucocorticoid-selective anti-inflammatory agents
11/22/2000EP1053233A1 Hydroxamic and carboxylic acid derivatives
11/22/2000EP1053226A1 Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
11/22/2000EP1053221A2 Lipid mixtures and their use
11/22/2000EP1052986A1 Anti-inflammatory agents
11/22/2000EP0736012B1 Anellated dihydropyridines and their use in the production of pharmaceutical preparations
11/22/2000EP0699180B1 Bicyclic amide derivatives and their use as muscle relaxants
11/22/2000CN1274344A Novel vitamin D analogues
11/22/2000CN1274283A Quinoline-containing & Alpha;-ketoamide cysteine and serine protease inhibitors
11/22/2000CN1274280A Delayed total release gastrointestinal drug delivery system
11/22/2000CN1273836A Fumaitong liquid and its preparing process
11/22/2000CN1273835A Chinese medicine for treating rheumatism
11/22/2000CN1273834A Chinese medicine for treating rheumatism
11/22/2000CN1273823A Analgesic composition for cancers in digestive system
11/22/2000CN1273819A Release-controlled Chinese-medicinal picking for reducing baby fever caused by cold
11/22/2000CN1058724C Use of steroid compound for preparing medicaments
11/22/2000CN1058632C Specific Chinese drug for curing common cold and abatement of fever
11/22/2000CN1058618C Traditional Chinese medicinal prepn. for relieving swelling and alleviating pain of throat, and its prodn. method
11/21/2000US6150557 Compounds
11/21/2000US6150539 Triptolide prodrugs having high aqueous solubility
11/21/2000US6150502 Polypeptides expressed in skin cells
11/21/2000US6150415 Epoxide hydrolase complexes and methods therewith
11/21/2000US6150413 Treatment of dermatological, rheumatic, respiratory, cardiovascular, bone and ophthalmological disorders, as well as mammalian skin and hair conditions; 4-(4-(biphenyl-2-yl)but-3-en-1-ynyl)benzoic acid, for example
11/21/2000US6150407 In a tissue or organ by contacting with a compound of given formula such as methyl-3,5-diiodo-4-(4'-methoxyphenoxy)benzoate; reducing the level of tumor necrosis factor alpha
11/21/2000US6150397 5-aroylnaphthalene derivatives as anti-inflammatory agents
11/21/2000US6150373 Bicyclic nitrogen heterocycles
11/21/2000US6150370 1,3-dinitrocyclic compound treats numerous diseases caused by undesired metalloprotease activity, such as tumor metastasis, osteoarthritis, rheumatoid arthritis, skin inflammation, ulcerations, and periodontitis
11/21/2000US6150326 Means for treating autoimmune diseases and method for the treatment thereof
11/21/2000US6150325 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical compositions
11/21/2000CA2083639C Substituted phenyl phenol leukotriene antagonists
11/21/2000CA2020477C Sustained release formulations of water soluble peptides
11/16/2000WO2000068380A2 Extracellular matrix and adhesion-associated proteins
11/16/2000WO2000068263A2 Stereoselective antifibrillogenic peptides and peptidomimetics thereof
11/16/2000WO2000068247A2 Serine proteases
11/16/2000WO2000068246A1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy
11/16/2000WO2000068231A1 Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof
11/16/2000WO2000068224A1 Substituted benzolactam compounds
1 ... 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 ... 1272